Engineering immune response to regulate cardiovascular disease and cancer

Area of Science:

• Immunology
• Cardiovascular Science
• Oncology

Background:

• Cardiovascular disease (CVD) and cancer are leading causes of global mortality.
• The immune system's role in the pathogenesis of both CVD and cancer is complex and interconnected.
• Shared immunological mechanisms, such as inflammation and immune cell involvement, link these distinct diseases.

Purpose of the Study:

• To explore the intricate relationship between the immune system and the pathogenesis of cardiovascular disease and cancer.
• To investigate the roles of innate and adaptive immunity, immune regulation, and immunotherapy in these conditions.
• To examine the impact of gut microbiota on CVD and cancer pathogenesis and potential therapeutic interventions.

Main Methods:

• Review of current literature on immunology, cardiovascular disease, and cancer.
• Analysis of the roles of innate and adaptive immune responses, including T cell subsets and regulatory mechanisms.
• Exploration of immunotherapy strategies and the influence of gut microbiota on disease progression.

Main Results:

• Innate and adaptive immunity significantly influence the initiation and progression of both CVD and cancer.
• Immune dysregulation and chronic inflammation are common underlying factors in both disease types.
• Immunotherapy, including immune checkpoint blockade and tolerance induction, shows promise for managing CVD and cancer.

Conclusions:

• Immunomodulatory strategies and immunotherapy hold significant potential for improving cardiovascular and cancer health.
• Harnessing the gut microbiota for immune modulation presents a novel therapeutic avenue.
• Personalized and precision medicine approaches are crucial for optimizing immunotherapeutic interventions.